QuidelOrtho Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 QuidelOrtho Corp 公司

QuidelOrtho Corporation 從事體外診斷、開發和製造智能解決方案。該公司通過直銷團隊和分銷商網絡將其產品直接銷售給最終用戶，供醫生辦公室、醫院、臨牀實驗室、參考實驗室、緊急護理診所、大學、零售診所、藥房、健康篩查中心、其他即時診斷 (POC) 場所、血庫和捐獻中心的專業使用，以及供個人、非專業、非處方 (OTC) 使用。該公司以各種品牌提供診斷測試解決方案，包括 AdenoPlus、BIOVUE、FreshCells、InflammaDry、Lyra、MeterPro、MicroVue、Ortho、Ortho Clinical Diagnostics、Ortho Connect、Ortho Plus、Ortho Vision、QuickVue、Quidel、QuidelOrtho、QVue、Savanna、Sofia、Solana、Thyretain、Triage、Virena、Vitros 等。它爲 130 多個國家和地區的客戶提供支持。

公司簡介

公司代碼QDEL

公司名稱QuidelOrtho Corp

上市日期Feb 01, 1991

成立日期2021

CEOMr. Brian J. Blaser

員工數量6600

證券類型Ordinary Share

年結日Feb 01

公司地址9975 Summers Ridge Road

城市SAN DIEGO

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編92121

電話18585521100

網址https://www.quidelortho.com/

公司代碼QDEL

上市日期Feb 01, 1991

成立日期2021

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

89.24K

--

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

67.62K

--

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

23.16K

+9.93%

Mr. Joseph M. Busky

Chief Financial Officer

19.17K

+20.97%

Mr. Edward L. (Ed) Michael

Independent Director

15.70K

--

Ms. Ann D. Rhoads

Independent Director

8.13K

--

Ms. Evelyn S. Dilsaver

Independent Director

--

Mr. Lee Bowman

Chief Human Resources Officer

--

Dr. Kenneth Jon (Ken) Widder, M.D.

Independent Director

--

Mr. Joseph D. Wilkins, Jr.

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

89.24K

--

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

67.62K

--

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

23.16K

+9.93%

Mr. Joseph M. Busky

Chief Financial Officer

19.17K

+20.97%

Mr. Edward L. (Ed) Michael

Independent Director

15.70K

--

Ms. Ann D. Rhoads

Independent Director

8.13K

--

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Labs

1.43B

51.27%

Point-of-Care

694.10M

24.94%

Immunohematology

522.60M

18.78%

Donor Screening

115.50M

4.15%

Molecular Diagnostic Solutions

24.00M

0.86%

地區USD

名稱

營收

佔比

United States

1.57B

56.37%

Foreign

1.21B

43.63%

業務

地區

業務USD

名稱

營收

佔比

Labs

1.43B

51.27%

Point-of-Care

694.10M

24.94%

Immunohematology

522.60M

18.78%

Donor Screening

115.50M

4.15%

Molecular Diagnostic Solutions

24.00M

0.86%

股東統計

更新時間: 2月23日週日

持股股東

股東類型

持股股東

股東統計

佔比

T. Rowe Price Investment Management, Inc.

16.66%

BlackRock Institutional Trust Company, N.A.

11.54%

The Vanguard Group, Inc.

10.08%

Rubric Capital Management LP

8.23%

Invesco Advisers, Inc.

4.78%

Other

48.71%

持股股東

股東統計

佔比

T. Rowe Price Investment Management, Inc.

16.66%

BlackRock Institutional Trust Company, N.A.

11.54%

The Vanguard Group, Inc.

10.08%

Rubric Capital Management LP

8.23%

Invesco Advisers, Inc.

4.78%

Other

48.71%

股東類型

股東統計

佔比

Investment Advisor

46.41%

Investment Advisor/Hedge Fund

38.01%

Hedge Fund

20.96%

Research Firm

1.63%

Sovereign Wealth Fund

1.20%

Pension Fund

1.17%

Individual Investor

0.78%

Bank and Trust

0.59%

Family Office

0.15%

機構持股

更新時間: 3月4日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

709

74.95M

111.12%

-12.34M

2024Q4

747

75.07M

111.30%

-13.02M

2024Q3

744

73.58M

109.44%

-4.02M

2024Q2

767

70.18M

104.79%

-7.57M

2024Q1

799

67.05M

100.24%

-5.28M

2023Q4

828

68.21M

102.09%

-2.95M

2023Q3

842

70.19M

105.17%

-4.01M

2023Q2

860

68.99M

103.61%

-6.94M

2023Q1

894

68.68M

103.29%

-6.80M

2022Q4

939

69.19M

108.75%

-5.89M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

T. Rowe Price Investment Management, Inc.

11.24M

16.66%

+1.84M

+19.59%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

7.79M

11.54%

+1.09M

+16.28%

Dec 31, 2024

The Vanguard Group, Inc.

6.80M

10.08%

-21.19K

-0.31%

Dec 31, 2024

Rubric Capital Management LP

5.55M

8.23%

+1.35M

+32.14%

Dec 31, 2024

Invesco Advisers, Inc.

3.23M

4.78%

+1.44M

+81.05%

Dec 31, 2024

State Street Global Advisors (US)

2.27M

3.37%

+366.13K

+19.19%

Dec 31, 2024

ArrowMark Colorado Holdings, LLC

1.98M

2.93%

+100.52K

+5.35%

Dec 31, 2024

D. E. Shaw & Co., L.P.

1.73M

2.56%

+50.77K

+3.03%

Dec 31, 2024

Fidelity Management & Research Company LLC

1.25M

1.85%

+30.51K

+2.50%

Dec 31, 2024

Dimensional Fund Advisors, L.P.

1.22M

1.8%

+107.78K

+9.72%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

Invesco S&P SmallCap Health Care ETF

1.57%

SPDR S&P Health Care Equipment ETF

1.45%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.89%

Ballast Small/Mid Cap ETF

0.48%

WisdomTree US SmallCap Quality Growth Fund

0.39%

SPDR S&P 600 Small Cap Value ETF

0.34%

iShares S&P Small-Cap 600 Value ETF

0.33%

VictoryShares US Small Mid Cap Value Momentum ETF

0.28%

Avantis US Small Cap Value ETF

0.27%

JPMorgan Fundamental Data Science Mid Core ETF

0.26%

Invesco S&P SmallCap Health Care ETF

佔比1.57%

SPDR S&P Health Care Equipment ETF

佔比1.45%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.89%

Ballast Small/Mid Cap ETF

佔比0.48%

WisdomTree US SmallCap Quality Growth Fund

佔比0.39%

SPDR S&P 600 Small Cap Value ETF

佔比0.34%

iShares S&P Small-Cap 600 Value ETF

佔比0.33%

VictoryShares US Small Mid Cap Value Momentum ETF

佔比0.28%

Avantis US Small Cap Value ETF

佔比0.27%

JPMorgan Fundamental Data Science Mid Core ETF

佔比0.26%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

QuidelOrtho Corp

28.580USD

QuidelOrtho Corp

28.580

概覽

公司